The following topics have been selected for the 7th Joint Call for Proposals by EQ Working Groups: Descriptive Systems RFP Descriptive Systems RFP_Add Valuation RFP Large Scale Health Applications RFP EQ-5D in Children RFP Education and Outreach RFP Innovative research…
The 3L and 5L Interviewer Administered versions (IA) were developed as amalgamated single versions to replace the Face-to-face and Telephone administered versions. This was done to facilitate the translation process, reduce costs to the users and reduce interviewer burden. A…
We kindly inform you that the Call for Abstracts for the 36th EuroQol Plenary Meeting on 18-21 September 2019 in Brussels, Belgium is now CLOSED. We kindly invite you to submit an abstract for next year's edition!
A series of papers on the EQ-5D has been published in the latest issue of Value in Health (ViH). Curated by guest editor and EuroQol Member, Andrew Lloyd, the themed section includes an overview of some current research initiatives on…
The Board of the EuroQol Research Foundation regularly reviews the EQ-5D user license policy. Recently, a decision has been made to extend free use to all non-commercial users. Therefore, as of today, 18 January 2019, the EuroQol Research Foundation will…
We are pleased to announce that EuroQol is hosting its 1st EuroQol Asia Academy Meeting in Guangzhou, China on 11-12 June 2019. The aim of this meeting edition is to support methodological studies in the region by bringing the EQ-5D researchers…
The EuroQol Office published a new version of the EQ-5D-3L User Guide, which is is now available for download at the EuroQol website: A change to the EQ-5D-3L, reflected in this User Guide update, has been made to the paper self-complete…
The following is an update on the current situation regarding the EQ-5D-5L value set for England. The EQ-5D-5L value set for England was published in 2018. Since then, in line with UK government quality assurance requirements, a first independent validation…
The EQ-5D has been used in clinical trials, population studies, and real world clinical settings for over 25 years and interest in using the instrument remains as strong as ever. From 1 October 2017 to 30 September 2018, 4,922 requests…
